scholarly journals Sex Differences in Risk for Alzheimer’s Disease Related to Neurotrophin Gene Polymorphisms: The Cache County Memory Study

2017 ◽  
Vol 72 (12) ◽  
pp. 1607-1613 ◽  
Author(s):  
Joshua Matyi ◽  
JoAnn T Tschanz ◽  
Gail B Rattinger ◽  
Chelsea Sanders ◽  
Elizabeth K Vernon ◽  
...  
2017 ◽  
Vol 73 (3) ◽  
pp. 311-311
Author(s):  
Joshua Matyi ◽  
JoAnn T Tschanz ◽  
Gail B Rattinger ◽  
Chelsea Sanders ◽  
Elizabeth K Vernon ◽  
...  

2019 ◽  
Vol 15 ◽  
pp. P834-P835
Author(s):  
Elizabeth K. Vernon ◽  
Gail B. Rattinger ◽  
Scott DeBerard ◽  
Jordan Kugler ◽  
JoAnn T. Tschanz

Author(s):  
Alejandra Freire Fernández-Regatillo ◽  
María L. de Ceballos ◽  
Jesús Argente ◽  
Sonia Díaz Pacheco ◽  
Clara González Martínez

Author(s):  
Jairo E. Martinez ◽  
Enmanuelle Pardilla-Delgado ◽  
Edmarie Guzmán-Vélez ◽  
Clara Vila-Castelar ◽  
Rebecca Amariglio ◽  
...  

Abstract Objective: Subjective Cognitive Decline (SCD) may be an early indicator of risk for Alzheimer’s disease (AD). Findings regarding sex differences in SCD are inconsistent. Studying sex differences in SCD within cognitively unimpaired individuals with autosomal-dominant AD (ADAD), who will develop dementia, may inform sex-related SCD variations in preclinical AD. We examined sex differences in SCD within cognitively unimpaired mutation carriers from the world’s largest ADAD kindred and sex differences in the relationship between SCD and memory performance. Methods: We included 310 cognitively unimpaired Presenilin-1 (PSEN-1) E280A mutation carriers (51% females) and 1998 noncarrier family members (56% females) in the study. Subjects and their study partners completed SCD questionnaires and the CERAD word list delayed recall test. ANCOVAs were conducted to examine group differences in SCD, sex, and memory performance. In carriers, partial correlations were used to examine associations between SCD and memory performance covarying for education. Results: Females in both groups had greater self-reported and study partner-reported SCD than males (all p < 0.001). In female mutation carriers, greater self-reported (p = 0.02) and study partner-reported SCD (p < 0.001) were associated with worse verbal memory. In male mutation carriers, greater self-reported (p = 0.03), but not study partner-reported SCD (p = 0.11) was associated with worse verbal memory. Conclusions: Study partner-reported SCD may be a stronger indicator of memory decline in females versus males in individuals at risk for developing dementia. Future studies with independent samples and preclinical trials should consider sex differences when recruiting based on SCD criteria.


2017 ◽  
Vol 13 (7) ◽  
pp. P1208
Author(s):  
Sebastian W. Atalla ◽  
Robert S. Anthony ◽  
Mary S. Dietrich ◽  
Ronald L. Cowan ◽  
Todd B. Monroe

2012 ◽  
Vol 8 (4S_Part_12) ◽  
pp. P452-P452
Author(s):  
Perry Ridge ◽  
Taylor Maxwell ◽  
Chris Corcoran ◽  
JoAnn Tschanz ◽  
Richard Cawthon ◽  
...  

1999 ◽  
Vol 20 (6) ◽  
pp. 591-596 ◽  
Author(s):  
D.H Salat ◽  
P.A Stangl ◽  
J.A Kaye ◽  
J.S Janowsky

2018 ◽  
Vol 8 (9) ◽  
pp. 163 ◽  
Author(s):  
Caroline Gurvich ◽  
Kate Hoy ◽  
Natalie Thomas ◽  
Jayashri Kulkarni

Hormones of the hypothalamic-pituitary-gonadal (HPG) axis that regulate reproductive function have multiple effects on the development, maintenance and function of the brain. Sex differences in cognitive functioning have been reported in both health and disease, which may be partly attributed to sex hormones. The aim of the current paper was to provide a theoretical review of how sex hormones influence cognitive functioning across the lifespan as well as provide an overview of the literature on sex differences and the role of sex hormones in cognitive decline, specifically in relation to Alzheimer’s disease (AD). A summary of current hormone and sex-based interventions for enhancing cognitive functioning and/or reducing the risk of Alzheimer’s disease is also provided.


Sign in / Sign up

Export Citation Format

Share Document